{"changes":[{"companyHref":"/c/climbbio-com","date":"2026-09-25","documentUrl":"https://www.sec.gov/Archives/edgar/data/1768446/000176844626000001/primary_doc.xml","domain":"climbbio.com","fact":"latest round","name":"Climb Bio, Inc.","new":{"amountUsd":110076289,"date":"2026-05-04","lead":null,"type":null},"old":{"amountUsd":110076289,"date":"2026-05-04","lead":null,"type":"seed"},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"climbbio-com","status":"sourced","url":"https://whoraisedwhat.com/c/climbbio-com"},{"companyHref":"/c/climbbio-com","date":"2026-09-25","documentUrl":"https://www.sec.gov/Archives/edgar/data/1768446/000176844626000001/primary_doc.xml","domain":"climbbio.com","fact":"provenance:round","name":"Climb Bio, Inc.","new":{"publisher":"SEC EDGAR","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1768446/000176844626000001/primary_doc.xml"},"old":{"publisher":"sec-edgar","status":"attributed","url":null},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"climbbio-com","status":"sourced","url":"https://whoraisedwhat.com/c/climbbio-com"}],"country":"US","description":"Climb Bio develops monoclonal antibody treatments targeting immune-mediated diseases such as lupus, kidney disorders, and immune thrombocytopenia. It serves patients with limited therapeutic options needing disease-modifying medicines. Antibodies target specific immune pathways rather than relying on broad immunosuppression.","domain":"climbbio.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":42.310549,"lng":-71.277031,"location":"WELLESLEY HILLS, MA","name":"Climb Bio, Inc.","rounds":[{"amountQuarantined":false,"amountUsd":110076289,"currency":"USD","date":"2026-05-04","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-25","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1768446/000176844626000001/primary_doc.xml"},"status":"sourced","type":null,"url":"https://www.sec.gov/Archives/edgar/data/1768446/000176844626000001/primary_doc.xml"}],"slug":"climbbio-com","sources":[{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-25","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1768446/000176844626000001/primary_doc.xml"},{"fact":"existence","publisher":"climbbio.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://climbbio.com"},{"fact":"description","publisher":"climbbio.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://climbbio.com"}],"stage":null,"techStack":["Cloudflare","WordPress","Yoast SEO 27.3","Google Analytics","Google Tag Manager","jQuery Migrate 3.4.1","DoubleClick Floodlight","Cloudflare Bot Management","WP Engine","MailChimp","Underscore.js","Backbone.js"],"totalRaisedUsd":110076289,"updatedAt":"2026-05-05"}